CA1214168A - 6-substituted-s-triazole¬3,4-a|phthalazine derivatives - Google Patents

6-substituted-s-triazole¬3,4-a|phthalazine derivatives

Info

Publication number
CA1214168A
CA1214168A CA000419398A CA419398A CA1214168A CA 1214168 A CA1214168 A CA 1214168A CA 000419398 A CA000419398 A CA 000419398A CA 419398 A CA419398 A CA 419398A CA 1214168 A CA1214168 A CA 1214168A
Authority
CA
Canada
Prior art keywords
formula
phenyl
compound
substituted
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000419398A
Other languages
English (en)
French (fr)
Inventor
Emilio Occelli
Domenico Barone
Adele Giunta
Giorgio Tarzia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA filed Critical Gruppo Lepetit SpA
Application granted granted Critical
Publication of CA1214168A publication Critical patent/CA1214168A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/34Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CA000419398A 1982-01-18 1983-01-13 6-substituted-s-triazole¬3,4-a|phthalazine derivatives Expired CA1214168A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8201273 1982-01-18
GB8201273 1982-01-18

Publications (1)

Publication Number Publication Date
CA1214168A true CA1214168A (en) 1986-11-18

Family

ID=10527683

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000419398A Expired CA1214168A (en) 1982-01-18 1983-01-13 6-substituted-s-triazole¬3,4-a|phthalazine derivatives

Country Status (20)

Country Link
US (1) US4788186A (instruction)
EP (1) EP0085840B1 (instruction)
JP (1) JPS58124786A (instruction)
KR (1) KR890000184B1 (instruction)
AT (1) ATE22562T1 (instruction)
AU (1) AU564026B2 (instruction)
CA (1) CA1214168A (instruction)
DE (1) DE3366494D1 (instruction)
DK (1) DK163145C (instruction)
ES (1) ES8601995A1 (instruction)
FI (1) FI81350C (instruction)
GR (1) GR78442B (instruction)
HU (1) HU193033B (instruction)
IE (1) IE55032B1 (instruction)
IL (1) IL67697A (instruction)
NO (1) NO161674C (instruction)
NZ (1) NZ203021A (instruction)
PH (1) PH21834A (instruction)
PT (1) PT76107A (instruction)
ZA (1) ZA83224B (instruction)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194310B (it) * 1983-07-12 1988-09-14 Lepetit Spa Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti
ATE236904T1 (de) * 1996-07-25 2003-04-15 Merck Sharp & Dohme Substituierte triazolo-pyridazin-derivate als liganden von gaba-rezeptoren
US6465462B1 (en) 1996-07-25 2002-10-15 Merck Sharp & Dohme Ltd. Substituted triazolo pyridazine derivatives as inverse agonists of the GABAAα5 receptor subtype
WO1998050385A1 (en) * 1997-05-08 1998-11-12 Merck Sharp & Dohme Limited SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS
GB9715977D0 (en) 1997-07-29 1997-10-01 Merck Sharp & Dohme Therapeutic agents
ES2137113B1 (es) * 1997-07-29 2000-09-16 Almirall Prodesfarma Sa Nuevos derivados de triazolo-piridazinas heterociclicos.
GB9723999D0 (en) 1997-11-13 1998-01-14 Merck Sharp & Dohme Therapeutic use
GB9726699D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
GB9726701D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
AU1041599A (en) * 1997-11-13 1999-06-07 Jose Luis Castro Pineiro Therapeutic uses of triazolo-pyridazine derivatives
GB9726702D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
US6110915A (en) * 1997-12-18 2000-08-29 Merck & Co., Inc. Antiemetic use of triazolo-pyridazine derivatives
JP2002509150A (ja) * 1998-01-14 2002-03-26 メルク シャープ エンド ドーム リミテッド Gaba受容体のリガンドとしてのトリアゾロピリダジン誘導体
GB9801202D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801208D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801234D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
MXPA00007135A (es) 1998-01-21 2002-11-07 Merck Sharp & Dohme Derivados de triazolo-piridazina como ligandos para receptores gaba.
GB9801210D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801397D0 (en) 1998-01-22 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801538D0 (en) 1998-01-23 1998-03-25 Merck Sharp & Dohme Pharmaceutical product
US6448249B1 (en) 1998-02-25 2002-09-10 Merck Sharp & Dohme Ltd. Substituted 1,2,4-triazolo[3,4-A]phthalazine derivatives as GABAα5 ligands
PL341975A1 (en) * 1998-02-25 2001-05-07 Merck Sharp & Dohme Substituted 1,2,4-triazole[3,4-a]phtalazine
GB9824897D0 (en) 1998-11-12 1999-01-06 Merck Sharp & Dohme Therapeutic compounds
JP2002529468A (ja) 1998-11-12 2002-09-10 メルク エンド カムパニー インコーポレーテッド GABA−Aα−5逆活性薬の治療性多形およびそのパモエート組成物
GB9929569D0 (en) * 1999-12-14 2000-02-09 Merck Sharp & Dohme Therapeutic agents
GB0028583D0 (en) 2000-11-23 2001-01-10 Merck Sharp & Dohme Therapeutic compounds
WO2002083140A1 (en) * 2001-04-10 2002-10-24 Merck & Co., Inc. Inhibitors of akt activity
EP1379250A2 (en) * 2001-04-10 2004-01-14 Merck & Co., Inc. A method of treating cancer
AU2003226301A1 (en) * 2002-04-08 2003-10-20 Merck And Co., Inc. Method of treating cancer
US20050054647A1 (en) * 2002-12-27 2005-03-10 Detlev Schuppan New pharmaceutical combination
KR101368093B1 (ko) * 2004-09-02 2014-03-14 다케다 게엠베하 트리아졸로프탈라진
AU2006204454B2 (en) 2005-01-05 2011-11-10 Takeda Gmbh Triazolophthalazines as PDE2-inhibitors
ES2397082T3 (es) 2005-01-05 2013-03-04 Nycomed Gmbh Triazoloftalazinas como inhibidores de PDE2
PH12012501361A1 (en) 2009-12-31 2012-10-22 Centro Nac De Investigaciones Oncologicas Cnio Tricyclic compounds for use as kinase inhibitors
CN103694244B (zh) * 2014-01-09 2016-03-30 郑州大学 3,6位取代-1,2,4-三氮唑并[3,4-a]酞嗪类化合物及其制备和用途
CN104016986B (zh) * 2014-03-13 2016-02-03 郑州大学 3-取代-6-(1-取代哌嗪基)-1,2,4-三氮唑并[3,4-a]酞嗪类化合物、其制备方法和用途
EP4279074A1 (en) * 2022-05-19 2023-11-22 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Azolo compounds for treatment of fibrotic diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB629177A (en) * 1945-12-21 1949-09-14 Ciba Ltd Manufacture of new hydrazine compounds and derivatives thereof
US2484029A (en) * 1945-12-21 1949-10-11 Ciba Pharm Prod Inc Hydrazine derivatives of pyridazine compounds
JPS5132598A (en) * 1974-09-13 1976-03-19 Eisai Co Ltd Toriazoro * 3 44 ee * futarajinjudotai no goseiho
JPS603080B2 (ja) * 1976-08-10 1985-01-25 三菱化学株式会社 S―トリアゾロ〔3,4 ―α〕〔5,6,7,8〕テトラヒドロ フタラジン類
GR70309B (instruction) * 1979-10-29 1982-09-08 Dow Chemical Co

Also Published As

Publication number Publication date
NO830110L (no) 1983-07-19
FI830100L (fi) 1983-07-19
ATE22562T1 (de) 1986-10-15
PH21834A (en) 1988-03-17
AU564026B2 (en) 1987-07-30
JPS58124786A (ja) 1983-07-25
US4788186A (en) 1988-11-29
KR890000184B1 (ko) 1989-03-09
GR78442B (instruction) 1984-09-27
JPH048428B2 (instruction) 1992-02-17
IE830082L (en) 1983-07-18
FI81350B (fi) 1990-06-29
DE3366494D1 (de) 1986-11-06
PT76107A (en) 1983-02-01
ES531458A0 (es) 1985-11-01
EP0085840B1 (en) 1986-10-01
NO161674B (no) 1989-06-05
IL67697A (en) 1990-02-09
IL67697A0 (en) 1983-05-15
DK163145C (da) 1992-06-22
EP0085840A1 (en) 1983-08-17
DK17983A (da) 1983-07-19
IE55032B1 (en) 1990-05-09
ES8601995A1 (es) 1985-11-01
AU1055083A (en) 1983-07-28
ZA83224B (en) 1983-10-26
NO161674C (no) 1989-09-13
NZ203021A (en) 1986-05-09
KR840003254A (ko) 1984-08-20
FI830100A0 (fi) 1983-01-12
HU193033B (en) 1987-08-28
FI81350C (fi) 1990-10-10
DK163145B (da) 1992-01-27
DK17983D0 (da) 1983-01-18

Similar Documents

Publication Publication Date Title
CA1214168A (en) 6-substituted-s-triazole¬3,4-a|phthalazine derivatives
EP2281815B1 (en) 4-(Acetylamino)-3-[(4-chlorophenyl)thio]-2-methyl-1H-indole-1-acetic acid ethyl ester intermediate compound
US4654342A (en) 6-(cyanoguanidinophenyl)pyridazinones as cardiac stimulants
EP0134946B1 (en) 3,6-Disubstituted-triazolo[3,4-a]phthalazine derivatives
US4585861A (en) 1,2,4-triazine derivatives
CA2211669A1 (en) 6-substituted pyrazolo [3,4-d¦ pyrimidin-4-ones and compositions and methods of use thereof
EP0077983B1 (en) Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same
EP0194161A2 (en) Cyclopenta[d]pyrimidine derivatives, their preparation and use
HK1005450B (en) Cyclopenta [d] pyrimidine derivatives, their preparation and use
US4581356A (en) Triazine derivatives, and pharmaceutical compositions comprising the same
CZ280697A3 (cs) 6 aryl-pyrazolo(3,4-d)pyrimidin-4-ony a kompozice je obsahující, a způsob jejich použití
CA1144165A (en) N-pyrrolyl pyridazineamines
WO2000047582A1 (en) Triazolo-pyridazine derivatives as ligands for gaba receptors
EP0181145A2 (en) Heterocyclic compounds
CA1054599A (fr) Derives de l'oxathiinno (1,4) (2,3-c) pyrrole' leur preparation et les compositions qui les contiennent
EP0274929A1 (fr) Nouveaux dérivés du pyrrole, leur préparation et les compositions pharmaceutiques qui les contiennent
EP0054816B1 (en) Process for preparing n-pyrrolyl-pyridazineamine derivatives
US4131674A (en) Naphtyridine derivatives
EP0675880A1 (en) Quinilone disulfide as intermediates
HK1149563B (en) 4-(acetylamino)-3-[(4-chlorophenyl)thio]-2-methyl-1h-indole-1-acetic acid ethyl ester intermediate compound
CZ20001145A3 (cs) Tricyklické triazolobenzazepinové deriváty

Legal Events

Date Code Title Description
MKEX Expiry